Berkeley, California
United States
231
2026-05-28
The entities that hold a legal rights for patent applications filed by inventor Doudna Jennifer A.:
Jennifer A. Doudna from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Compositions and Methods for Targeted Delivery of CRISPR-CAS Effector Polypeptides and Transgenes
#2 | 2026-02-19Compositions and Methods for Targeted Delivery of CRISPR-CAS Effector Polypeptides
#3 | 2026-01-15COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS
#4 | 2026-01-15COMPOSITIONS AND METHODS FOR MODIFICATION OF TARGET MOLECULES
#5 | 2026-01-08Methods and Kits for Identifying Cancer Treatment Targets
#6 | 2025-10-16COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS
#7 | 2025-10-09CRISPR-Cas Effector Polypeptides and Methods of Use Thereof
#8 | 2025-06-26CASZ COMPOSITIONS AND METHODS OF USE
#9 | 2025-05-08Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription
#10 | 2025-04-24TEMPERATURE REGULATED CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF
#11 | 2025-04-17Methods and Compositions for RNA-Directed Target DNA Modification and for RNA-Directed Modulation of Transcription
#12 | 2025-04-01CasZ compositions and methods of use
#13 | 2024-12-19Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription
#14 | 2024-09-12CLASS 2 CRISPR/CAS COMPOSITIONS AND METHODS OF USE
#15 | 2024-06-27Methods and kits for identifying cancer treatment targets
#16 | 2024-06-06METHODS AND COMPOSITIONS FOR DETECTING A TARGET RNA
#17 | 2024-05-23RNA-GUIDED NUCLEIC ACID MODIFYING ENZYMES AND METHODS OF USE THEREOF
#18 | 2024-05-23COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS
#19 | 2024-05-23CASZ COMPOSITIONS AND METHODS OF USE
#20 | 2024-03-28CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#21 | 2024-01-25COMPOSITIONS AND METHODS FOR MODIFYING RNA
#22 | 2024-01-25CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#23 | 2023-12-21CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#24 | 2023-11-02CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#25 | 2023-10-19CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#26 | 2023-10-12COMPOSITIONS AND METHODS FOR INCREASING HOMOLOGY-DIRECTED REPAIR
#27 | 2023-10-12CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#28 | 2023-10-12CASZ COMPOSITIONS AND METHODS OF USE
#29 | 2023-09-21CRISPR-CAS BASED SYSTEM FOR TARGETING SINGLE-STRANDED SEQUENCES
#30 | 2023-09-14CRISPR-Cas effector polypeptides and methods of use thereof
#31 | 2023-07-20METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#32 | 2023-07-06METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA DIRECTED MODULATION OF TRANSCRIPTION
#33 | 2023-06-22COMPOSITIONS AND METHODS FOR DELIVERING CRISPR/CAS EFFECTOR POLYPEPTIDES
#34 | 2023-05-30CRISPR-Cas based system for targeting single-stranded sequences
#35 | 2023-03-16COMPOSITIONS AND METHODS FOR IDENTIFYING HOST CELL TARGET PROTEINS FOR TREATING RNA VIRUS INFECTIONS
#36 | 2023-03-02TRANSPOSON SYSTEMS FOR GENOME EDITING
#37 | 2023-01-26CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#38 | 2022-12-22COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF CRISPR-CAS EFFECTOR POLYPEPTIDES AND TRANSGENES
#39 | 2022-12-15RNA-guided nucleic acid modifying enzymes and methods of use thereof
#40 | 2022-10-27Genetically engineered cells
#41 | 2022-10-06VARIANT TYPE V CRISPR/CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#42 | 2022-09-08COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS
#43 | 2022-08-25Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#44 | 2022-08-25Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#45 | 2022-08-25Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#46 | 2022-08-18Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#47 | 2022-08-11Methods and kits for identifying cancer treatment targets
#48 | 2022-05-19COMPOSITIONS AND METHODS FOR MODIFICATION OF TARGET MOLECULES
#49 | 2022-04-28METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#50 | 2022-04-21METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#51 | 2022-04-21METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#52 | 2022-04-21METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#53 | 2022-04-21METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#54 | 2022-04-14METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#55 | 2022-03-10METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#56 | 2022-02-17Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#57 | 2022-01-27Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#58 | 2022-01-27NANOPORE MEMBRANE DEVICE AND METHODS OF USE THEREOF
#59 | 2022-01-13Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#60 | 2021-12-30CRISPR-Cas12J effector polypeptides and methods of use thereof
#61 | 2021-12-16Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
#62 | 2021-12-16Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#63 | 2021-12-16Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#64 | 2021-12-09CRISPR-Cas effector polypeptides and methods of use thereof
#65 | 2021-11-18Methods and kits for identifying cancer treatment targets
#66 | 2021-11-04Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#67 | 2021-11-04Modulators of CAS9 polypeptides and methods of use thereof
#68 | 2021-10-28Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#69 | 2021-10-28Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#70 | 2021-10-21CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#71 | 2021-10-21CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#72 | 2021-10-14REPORTER NUCLEIC ACIDS FOR TYPE V CRISPR-MEDIATED DETECTION
#73 | 2021-10-14CRISPR-Cas effector polypeptides and methods of use thereof
#74 | 2021-10-14Modified cells comprising CRISPR systems
#75 | 2021-10-07METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#76 | 2021-10-07Variant type V CRISPR/Cas effector polypeptides and methods of use thereof
#77 | 2021-09-30CRISPR-Cas effector polypeptides and methods of use thereof
#78 | 2021-09-16RNA-GUIDED NUCLEIC ACID MODIFYING ENZYMES AND METHODS OF USE THEREOF
#79 | 2021-09-02METHODS FOR DETECTING AND SEQUENCING A TARGET NUCLEIC ACID
#80 | 2021-09-02RNA-GUIDED EFFECTOR PROTEINS AND METHODS OF USE THEREOF
#81 | 2021-08-19CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#82 | 2021-08-05CRISPR-Cas effector polypeptides and methods of use thereof
#83 | 2021-07-29Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#84 | 2021-07-22Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#85 | 2021-07-15Class 2 CRISPR/Cas compositions and methods of use
#86 | 2021-04-15Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#87 | 2021-04-01Modulators of Cas9 polypeptide activity and methods of use thereof
#88 | 2021-03-25Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#89 | 2021-03-18Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#90 | 2021-03-04Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#91 | 2021-03-04Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#92 | 2021-03-04Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#93 | 2021-03-04Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#94 | 2021-01-21CasZ compositions and methods of use
#95 | 2020-12-24Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
#96 | 2020-12-17Thermostable RNA-guided endonucleases and methods of use thereof
#97 | 2020-11-26CasZ compositions and methods of use
#98 | 2020-11-19Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#99 | 2020-11-12Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#100 | 2020-11-12Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
262060 ⎘